🩺 𝘕𝘦𝘸 𝘪𝘯 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘏𝘦𝘮𝘢𝘵𝘰𝘭𝘰𝘨𝘺 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘰𝘯𝘢𝘭! 𝗨𝗻𝘃𝗲𝗶𝗹𝗶𝗻𝗴 𝘁𝗵𝗲 𝗺𝗮𝗻𝘆 𝗳𝗮𝗰𝗲𝘀 𝗼𝗳 𝗘𝗿𝗱𝗵𝗲𝗶𝗺-𝗖𝗵𝗲𝘀𝘁𝗲𝗿 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝘙𝘦𝘢𝘥 𝘵𝘩𝘦 𝘧𝘶𝘭𝘭 𝘢𝘳𝘵𝘪𝘤𝘭𝘦 𝘩𝘦𝘳𝘦 ⤵️ https://t.co/4149XLThnZ 𝘍𝘪𝘯𝘥 𝘪𝘵 𝘢𝘭𝘴𝘰

🎓 𝘖𝘶𝘳 𝘭𝘢𝘵𝘦𝘴𝘵 𝘐𝘈𝘊𝘏 𝘗𝘰𝘴𝘵 𝘐𝘈𝘊𝘏 2025 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 𝗣𝗼𝗹𝘆𝗰𝘆𝘁𝗵𝗲𝗺𝗶𝗮 𝗩𝗲𝗿𝗮: 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘸𝘪𝘵𝘩 𝘭𝘦𝘤𝘵𝘶𝘳𝘦𝘴 𝘣𝘺 𝘈𝘥𝘢𝘮 𝘔𝘦𝘢𝘥 & 𝘚𝘶𝘴𝘢𝘯𝘯𝘦 𝘐𝘴𝘧𝘰𝘳𝘵 📽️𝘕𝘰𝘸

NEW JERSEY: Get to know MIKIE SHERRILL: —Voted to RAISE taxes by $3,700 —Voted to give ILLEGALS taxpayer-funded healthcare —Voted to CUT the child tax credit And Sherrill has NO idea what to do as Governor. 🤯 Vote AGAINST her on Nov. 4th.

✨𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘶𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘸𝘦𝘣𝘪𝘯𝘢𝘳: 𝗨𝗽𝗱𝗮𝘁𝗲𝘀 𝗶𝗻 𝗖𝗔𝗥 𝗧 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗳𝗼𝗿 𝗟𝗮𝗿𝗴𝗲 𝗕 𝗖𝗲𝗹𝗹 𝗟𝘆𝗺𝗽𝗵𝗼𝗺𝗮 🗓 𝘛𝘶𝘦𝘴𝘥𝘢𝘺, 𝘕𝘰𝘷𝘦𝘮𝘣𝘦𝘳 4, 2025 ⏰6𝘱𝘮 𝘊𝘌𝘛 💻𝘙𝘦𝘨𝘪𝘴𝘵𝘦𝘳 𝘧𝘰𝘳 𝘍𝘙𝘌𝘌 https://t.co/YZBaBZiUVO

𝘏𝘢𝘱𝘱𝘦𝘯𝘪𝘯𝘨 𝘕𝘰𝘸 𝗣𝗼𝗹𝘆𝗰𝘆𝘁𝗵𝗲𝗺𝗶𝗮 𝗩𝗲𝗿𝗮: 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘸𝘪𝘵𝘩 𝘭𝘦𝘤𝘵𝘶𝘳𝘦𝘴 𝘣𝘺 𝘈𝘥𝘢𝘮 𝘔𝘦𝘢𝘥 & 𝘚𝘶𝘴𝘢𝘯𝘯𝘦 𝘐𝘴𝘧𝘰𝘳𝘵 💻𝘙𝘦𝘨𝘪𝘴𝘵𝘦𝘳 𝘧𝘰𝘳 𝘍𝘙𝘌𝘌 https://t.co/7IjVkJsM4K

𝗛𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗧𝗢𝗗𝗔𝗬 🎟️ 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘: https://t.co/7IjVkJsM4K @Mohty_EBMT @SIsfort

Model Y Standard & Model 3 Standard are here

✨𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘶𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘸𝘦𝘣𝘪𝘯𝘢𝘳: 𝗨𝗽𝗱𝗮𝘁𝗲𝘀 𝗶𝗻 𝗖𝗔𝗥 𝗧 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗳𝗼𝗿 𝗟𝗮𝗿𝗴𝗲 𝗕 𝗖𝗲𝗹𝗹 𝗟𝘆𝗺𝗽𝗵𝗼𝗺𝗮 🗓 𝘛𝘶𝘦𝘴𝘥𝘢𝘺, 𝘕𝘰𝘷𝘦𝘮𝘣𝘦𝘳 4, 2025 ⏰6𝘱𝘮 𝘊𝘌𝘛 💻𝘙𝘦𝘨𝘪𝘴𝘵𝘦𝘳 𝘧𝘰𝘳 𝘍𝘙𝘌𝘌 https://t.co/YZBaBZiUVO

🎥 𝘕𝘰𝘸 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘰𝘯 𝘥𝘦𝘮𝘢𝘯𝘥! 𝘢 𝘴𝘱𝘦𝘤𝘪𝘢𝘭 𝘐𝘈𝘊𝘏 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 𝗜𝗻 𝗠𝗲𝗺𝗼𝗿𝗶𝗮𝗺 𝗼𝗳 𝗗𝗿 𝗕𝗿𝗶𝗮𝗻 𝗗𝘂𝗿𝗶𝗲: 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀’ 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝗮𝗻𝗱 𝗔𝗱𝘃𝗼𝗰𝗮𝗰𝘆 💻𝘞𝘢𝘵𝘤𝘩 𝘪𝘵 𝘍𝘙𝘌𝘌 𝘩𝘦𝘳𝘦 → https://t.co/ydzDbUwCqs

𝗛𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗼𝗻 𝗪𝗘𝗗𝗡𝗘𝗦𝗗𝗔𝗬 🎟️ 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘: https://t.co/7IjVkJsM4K @Mohty_EBMT @SIsfort

IACH NEWS OF THE WEEK • Oct. 26, 2025 🗞️ • @TheIACH @Mohty_EBMT Topics: - JAK2 Unmutated erythrocytosis @AjHematology - MCL guidelines @EHA_Hematology - Age-Related Decline in Lymphocyte Counts - Elranatamab in R/R AL Amyloidosis 🔗 https://t.co/TP9Rtsofxf

FUTURES TRADERS: Get 40% off all evals, no activation fees, end-of-day drawdown in our live-market PRO+ accounts…and still daily PRO payouts!

🎥 𝘕𝘰𝘸 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘰𝘯 𝘥𝘦𝘮𝘢𝘯𝘥! 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗜𝗠𝗦 𝟮𝟬𝟮𝟱: 𝗔 𝗙𝗼𝗰𝘂𝘀 𝗼𝗻 𝗖𝗘𝗟𝗠𝗼𝗗𝘀 𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘦𝘥 𝘣𝘺 𝘋𝘳. 𝘙𝘢𝘩𝘶𝘭 𝘉𝘢𝘯𝘦𝘳𝘫𝘦𝘦 🎬 𝘞𝘢𝘵𝘤𝘩 𝘪𝘵 𝘍𝘙𝘌𝘌 𝘩𝘦𝘳𝘦 → https://t.co/ydzDbUwCqs @RahulBanerjeeMD

𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘶𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘗𝘰𝘴𝘵 𝘐𝘈𝘊𝘏 2025 𝘈𝘯𝘯𝘶𝘢𝘭 𝘊𝘰𝘯𝘨𝘳𝘦𝘴𝘴 𝗣𝗼𝗹𝘆𝗰𝘆𝘁𝗵𝗲𝗺𝗶𝗮 𝗩𝗲𝗿𝗮: 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘸𝘪𝘵𝘩 𝘭𝘦𝘤𝘵𝘶𝘳𝘦𝘴 𝘣𝘺 𝘈𝘥𝘢𝘮 𝘔𝘦𝘢𝘥 & 𝘚𝘶𝘴𝘢𝘯𝘯𝘦

Celebrating 35 years of academic excellence! The IFM has led groundbreaking trials shaping the modern era of high-dose therapy in myeloma. Proud to see this legacy highlighted in ⁦@BloodCancerJnl⁩ , showcasing how IFM research has set global standards for myeloma care.

Thanks @TheIACH! Ultimately, CELMoDs work so dramatically differently in terms of efficacy & safety (with or without prior IMiD exposure) that they're a whole new class when it comes to manuscript Table 1s and formularies around the world. Excited to have these in clinic soon!

Honored to have led this long-term follow-up analysis of the REACH2 trial, a landmark study that paved the way for the 1st approved treatment in steroid-refractory aGVHD. Deeply grateful to all investigators, study teams, and stakeholders whose dedication made this achievement

𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘶𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘗𝘰𝘴𝘵 𝘐𝘈𝘊𝘏 2025 𝘈𝘯𝘯𝘶𝘢𝘭 𝘊𝘰𝘯𝘨𝘳𝘦𝘴𝘴 𝗣𝗼𝗹𝘆𝗰𝘆𝘁𝗵𝗲𝗺𝗶𝗮 𝗩𝗲𝗿𝗮: 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘸𝘪𝘵𝘩 𝘭𝘦𝘤𝘵𝘶𝘳𝘦𝘴 𝘣𝘺 𝘈𝘥𝘢𝘮 𝘔𝘦𝘢𝘥 & 𝘚𝘶𝘴𝘢𝘯𝘯𝘦

The Century Foundation isn’t just a think tank—it’s an operator connecting money, media, and power.

🎥 𝘕𝘰𝘸 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘰𝘯 𝘥𝘦𝘮𝘢𝘯𝘥! 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗜𝗠𝗦 𝟮𝟬𝟮𝟱: 𝗔 𝗙𝗼𝗰𝘂𝘀 𝗼𝗻 𝗖𝗘𝗟𝗠𝗼𝗗𝘀 𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘦𝘥 𝘣𝘺 𝘋𝘳. 𝘙𝘢𝘩𝘶𝘭 𝘉𝘢𝘯𝘦𝘳𝘫𝘦𝘦 🎬 𝘞𝘢𝘵𝘤𝘩 𝘪𝘵 𝘍𝘙𝘌𝘌 𝘩𝘦𝘳𝘦 → https://t.co/ydzDbUwCqs @RahulBanerjeeMD

𝘏𝘢𝘱𝘱𝘦𝘯𝘪𝘯𝘨 𝘕𝘰𝘸 𝗜𝗻 𝗠𝗲𝗺𝗼𝗿𝗶𝗮𝗺 𝗼𝗳 𝗗𝗿 𝗕𝗿𝗶𝗮𝗻 𝗗𝘂𝗿𝗶𝗲: 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀’ 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝗮𝗻𝗱 𝗔𝗱𝘃𝗼𝗰𝗮𝗰𝘆 💻𝘙𝘦𝘨𝘪𝘴𝘵𝘦𝘳 𝘧𝘰𝘳 𝘍𝘙𝘌𝘌 https://t.co/GF887BzrE2 @Mohty_EBMT

🎓 𝘖𝘶𝘳 𝘭𝘢𝘵𝘦𝘴𝘵 𝘐𝘈𝘊𝘏 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘊𝘭𝘶𝘣 𝘰𝘯 𝘴𝘪𝘵𝘦! 𝗦𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝗘𝗳𝗳𝗶𝗰𝗮𝗰𝘆 𝗼𝗳 𝗘𝗹𝗿𝗮𝗻𝗮𝘁𝗮𝗺𝗮𝗯 𝗶𝗻 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗥𝗲𝗹𝗮𝗽𝘀𝗲𝗱 𝗮𝗻𝗱/𝗼𝗿 𝗥𝗲𝗳𝗿𝗮𝗰𝘁𝗼𝗿𝘆 𝗶𝗺𝗺𝘂𝗻𝗼𝗴𝗹𝗼𝗯𝘂𝗹𝗶𝗻 𝗟𝗶𝗴𝗵𝘁-𝗖𝗵𝗮𝗶𝗻

𝗛𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗧𝗢𝗠𝗢𝗥𝗥𝗢𝗪 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘 @Mohty_EBMT

https://t.co/KL8Z3ki9Pl

🎓 𝘖𝘶𝘳 𝘭𝘢𝘵𝘦𝘴𝘵 𝘐𝘈𝘊𝘏 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘊𝘭𝘶𝘣 𝘰𝘯 𝘴𝘪𝘵𝘦! 𝗦𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝗘𝗳𝗳𝗶𝗰𝗮𝗰𝘆 𝗼𝗳 𝗘𝗹𝗿𝗮𝗻𝗮𝘁𝗮𝗺𝗮𝗯 𝗶𝗻 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗥𝗲𝗹𝗮𝗽𝘀𝗲𝗱 𝗮𝗻𝗱/𝗼𝗿 𝗥𝗲𝗳𝗿𝗮𝗰𝘁𝗼𝗿𝘆 𝗶𝗺𝗺𝘂𝗻𝗼𝗴𝗹𝗼𝗯𝘂𝗹𝗶𝗻 𝗟𝗶𝗴𝗵𝘁-𝗖𝗵𝗮𝗶𝗻